These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
395 related items for PubMed ID: 20042535
1. Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocol effects. Haouzi D, Assou S, Dechanet C, Anahory T, Dechaud H, De Vos J, Hamamah S. Biol Reprod; 2010 Apr; 82(4):679-86. PubMed ID: 20042535 [Abstract] [Full Text] [Related]
7. Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression. Cavagna M, Maldonado LG, de Souza Bonetti TC, de Almeida Ferreira Braga DP, Iaconelli A, Borges E. Fertil Steril; 2010 Jun; 94(1):167-72. PubMed ID: 19342035 [Abstract] [Full Text] [Related]
9. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Ruan HC, Zhu XM, Luo Q, Liu AX, Qian YL, Zhou CY, Jin F, Huang HF, Sheng JZ. Hum Reprod; 2006 Oct; 21(10):2521-9. PubMed ID: 16790614 [Abstract] [Full Text] [Related]
11. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Simon C, Oberyé J, Bellver J, Vidal C, Bosch E, Horcajadas JA, Murphy C, Adams S, Riesewijk A, Mannaerts B, Pellicer A. Hum Reprod; 2005 Dec; 20(12):3318-27. PubMed ID: 16085660 [Abstract] [Full Text] [Related]
18. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Acevedo B, Gomez-Palomares JL, Ricciarelli E, Hernández ER. Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344 [Abstract] [Full Text] [Related]
19. GnRH agonist long protocol vs. a single 3-mg gnRH antagonist: a comparison of 2 protocols for pituitary down-regulation in oocyte donor-controlled ovarian hyperstimulation cycles. Erb TM, Wakim AN. J Reprod Med; 2008 May; 53(5):331-7. PubMed ID: 18567278 [Abstract] [Full Text] [Related]
20. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P. Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]